Lead Moderators | @NEJM Ask the Authors & Experts: Targeting CD38 with... | NEJM Resident 360

@NEJM Ask the Authors & Experts: Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Q&A has ended

Authors
Niels van de Donk, MD PhD

Hematologist, Multiple Myeloma Specialist, VU University Medical Center Amsterdam

Niels van de Donk, MD PhD

Niels van de Donk, MD PhD

Hematologist, Multiple Myeloma Specialist, VU University Medical Center Amsterdam

Hematologist, Multiple Myeloma Specialist, VU University Medical Center Amsterdam
Paul Richardson, MD

Clinical Program Leader & Director of Clinical Research, Jerome Lipper Multiple Myeloma Center, Dana Farber

Paul Richardson, MD

Paul Richardson, MD

Clinical Program Leader & Director of Clinical Research, Jerome Lipper Multiple Myeloma Center, Dana Farber

Clinical Program Leader & Director of Clinical Research, Jerome Lipper Multiple Myeloma Center, Dana Farber
Torben Plesner, M.D., Doc. Med. Sci.

Founder and Leader of the Clinical Research Unit, Dept of Hematology, Vejle Hospital

Torben Plesner, M.D., Doc. Med. Sci.

Torben Plesner, M.D., Doc. Med. Sci.

Founder and Leader of the Clinical Research Unit, Dept of Hematology, Vejle Hospital

Founder and Leader of the Clinical Research Unit, Dept of Hematology, Vejle Hospital

Experts
Irene Ghobrial, MD

Director, Michele & Stephen Kirsch Laboratory, Dana-Farber Cancer Institute

Irene Ghobrial, MD

Irene Ghobrial, MD

Director, Michele & Stephen Kirsch Laboratory, Dana-Farber Cancer Institute

Director, Michele & Stephen Kirsch Laboratory, Dana-Farber Cancer Institute
James Driscoll, MD, PhD

Medical Oncologist and Translational Researcher, University of Cincinnati Cancer Institute

James Driscoll, MD, PhD

James Driscoll, MD, PhD

Medical Oncologist and Translational Researcher, University of Cincinnati Cancer Institute

Medical Oncologist and Translational Researcher, University of Cincinnati Cancer Institute
Martha Lacy, MD

Chair of Hematology and Professor of Medicine at Mayo Clinic

Martha Lacy, MD

Martha Lacy, MD

Chair of Hematology and Professor of Medicine at Mayo Clinic

Chair of Hematology and Professor of Medicine at Mayo Clinic
Saad Usmani, M.D., FACP

Director of Plasma Cell Disorder Program, Levine Cancer Institute/Carolinas Healthcare System

Saad Usmani, M.D., FACP

Saad Usmani, M.D., FACP

Director of Plasma Cell Disorder Program, Levine Cancer Institute/Carolinas Healthcare System

Director of Plasma Cell Disorder Program, Levine Cancer Institute/Carolinas Healthcare System
David Avigan, MD

Chief, Hematological Malignancies & Bone Marrow Transplantation, BIDMC

David Avigan, MD

David Avigan, MD

Chief, Hematological Malignancies & Bone Marrow Transplantation, BIDMC

Chief, Hematological Malignancies & Bone Marrow Transplantation, BIDMC
Giada Bianchi, MD

Senior Fellow, Jerome Lipper Multiple Myeloma Center, Dana Farber

Giada Bianchi, MD

Giada Bianchi, MD

Senior Fellow, Jerome Lipper Multiple Myeloma Center, Dana Farber

Senior Fellow, Jerome Lipper Multiple Myeloma Center, Dana Farber
Shaji Kumar, MD

Professor of Medicine, Hematology at Mayo Clinic

Shaji Kumar, MD

Shaji Kumar, MD

Professor of Medicine, Hematology at Mayo Clinic

Professor of Medicine, Hematology at Mayo Clinic
Constantine Mitsiades, MD, PhD

Assistant Professor in Medicine, Medical Oncology, Dana-Farber Cancer Institute

Constantine Mitsiades, MD, PhD

Constantine Mitsiades, MD, PhD

Assistant Professor in Medicine, Medical Oncology, Dana-Farber Cancer Institute

Assistant Professor in Medicine, Medical Oncology, Dana-Farber Cancer Institute

Lead Moderators
Elizabeth O'Donnell, MD

Hematologist-Oncologist, Center for Multiple Myeloma, MGH

Elizabeth O'Donnell, MD

Elizabeth O'Donnell, MD

Hematologist-Oncologist, Center for Multiple Myeloma, MGH

Hematologist-Oncologist, Center for Multiple Myeloma, MGH

Moderators
Francesca Cottini, MD

Internal medicine resident, Ohio State University

Francesca Cottini, MD

Francesca Cottini, MD

Internal medicine resident, Ohio State University

Internal medicine resident, Ohio State University
Aziz Nazha, MD

Hematology & Oncology Fellow, Taussig Cancer Institute, Cleveland Clinic

Aziz Nazha, MD

Aziz Nazha, MD

Hematology & Oncology Fellow, Taussig Cancer Institute, Cleveland Clinic

Hematology & Oncology Fellow, Taussig Cancer Institute, Cleveland Clinic

Lead Moderators

Elizabeth O'Donnell, MD
- Hematology and Oncology
Hematologist-Oncologist, Center for Multiple Myeloma, MGH

Hematologist-Oncologist, Center for Multiple Myeloma, MGH
Instructor in Medicine at Massachusetts General Hospital/ Harvard Medical School
View Profile
Elizabeth O'Donnell, MD is a hematologist-oncologist at the Center for Multiple Myeloma at the Massachusetts General Hospital.